MedTrace Logo

Timing of Coronary Angiography, Cardiac Surgery, and Adverse Renal and Cardiac Events (MARCE)

NCT02332070 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 965

Last updated 2018-02-12

No results posted yet for this study

Summary

1. To examine two main predictor variables independently and then jointly in stratified and multivariate analyses for the outcomes of CSA-AKI, MARCE, need for RRT, and inpatient mortality, and the composite, as well as the outcomes of 30 day rehospitalization or death, and finally for the days out of hospital and alive adjusted to person-year of time

1. Days from coronary angiogram performed with IOCM to cardiac surgery (1, 2, 3, etc)
2. Thakar Acute Renal Failure (ARF) score (1 to 17)
2. To examine the interrelationships between time in days between angiogram and surgery and the ARF Score with the Society of Thoracic Surgery (STS) Risk score for mortality

Conditions

Interventions

PROCEDURE

cardiac surgery

coronary artery bypass surgery and or cardiac valve surgery with cardiopulmonary bypass

Sponsors & Collaborators

  • GE Healthcare

    collaborator INDUSTRY

  • Baylor Research Institute

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-02-28
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02332070 on ClinicalTrials.gov